95 Finance Monthly. Transaction Reports also support drug and medical device manufacturers and healthcare service providers as well as investment funds, entrepreneurs and public and private healthcare institutions. With more than 230 lawyers in 12 offices, including 11 abroad, LPA-CGR avocats is one of France’s top 10 independent law firms that offers a comprehensive range of services in all the main areas of business law and in several business sectors, including healthcare. That is why our cross services offer includes IP/IT, distribution, litigation, corporate law and M&A, tax law, labour law, public law and regulatory/compliance, in France and abroad. Mathieu: Within the life sciences sector, our team of 15 lawyers is deeply dedicated to the healthcare industry to cover our clients’ legal needs. With the arrival of Morgane Morey in November 2022, we reinforced our strategic approach of the market by integrating the regulatory aspect. As Morgane has been working for more than 10 years on regulatory matters throughout the life cycle of health and health-related products, including medicinal products, medical devices, cosmetics and food supplements, she has developed an expertise on legal and regulatory counselling, contracts and audits, in particular on mergers and acquisitions, mainly upon demand of the industry. She also intervenes in commercial and product liability litigation. For example, in addition to the issues that arise throughout the life cycle of healthcare products, Morgane is currently working on a serial defective product dispute, a dispute challenging an ANSM decision on the banning of HHC and is assisting a client with criminal proceedings that are just getting underway. How does your offer differ from that of other firms? Raphaël: We are involved in various health initiatives. For example, the team is an active member of France Biotech, a French association created in 1997 that brings together the main innovative entrepreneurs in HealthTech and their expert partners. France Biotech’s primary mission is to support the development of this industry in France. We are part of their numerous committees. Mathieu: We have also a strong relationship with unions of the sector (LEEM, SNITEM, GEMME, AFAR, etc.) as well as with opinion leaders to influence the content of future legislation. Raphaël: As the life sciences / healthcare area is one of our priority development sectors, we are doing our utmost! LPA-CGR avocats desires to position itself at the heart of its clients’ strategic issues by providing them with a comprehensive, cutting-edge life sciences and healthcare offer. Raphaël Chantelot Partner Mathieu Selva-Roudon Partner
RkJQdWJsaXNoZXIy Mjk3Mzkz